• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Female Infertility - Pipeline Review, H1 2012 Product Image

Female Infertility - Pipeline Review, H1 2012

  • Published: February 2012
  • 158 pages
  • Global Markets Direct

Female Infertility – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Female Infertility - Pipeline Review, H1 2012', provides an overview of the Female Infertility therapeutic pipeline. This report provides information on the therapeutic development for Female Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Infertility. 'Female Infertility - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Female Infertility.
- A review of the Female Infertility products under development by companies and universities/research READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Female Infertility Overview
Therapeutics Development
An Overview of Pipeline Products for Female Infertility
Female Infertility Therapeutics under Development by Companies
Female Infertility Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Female Infertility Therapeutics – Products under Development by Companies
Female Infertility Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Female Infertility Therapeutics Development
Abbott Laboratories
Vyteris, Inc.
Watson Pharmaceuticals, Inc.
Merck & Co., Inc.
Euroscreen S.A.
Takeda Pharmaceutical Company Limited
ASKA Pharmaceutical Co., Ltd
Astellas Pharma Inc.
Dong-A Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Limited
Zydus Cadila Healthcare Limited
Pantec Biosolutions AG
Merck KGaA
Access Pharmaceuticals, Inc.
Addex Pharmaceuticals
AEterna Zentaris Inc.
Soligenix, Inc.
Repros Therapeutics Inc.
Protalix BioTherapeutics, Inc.
Glycotope GmbH
Peptron, Inc.
Meditrina Pharmaceuticals, Inc.
PregLem SA
Ferring Pharmaceuticals, Inc.
Isifer AB
Female Infertility – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AEZS-115 - Drug Profile
TAK-385 - Drug Profile
Anastrozole - Drug Profile
Elagolix - Drug Profile
ADX68692 - Drug Profile
GnRH Antagonists - Drug Profile
GnRH Patch - Drug Profile
Proellex - Drug Profile
Recombinant Hormones For Ovulation Induction - Drug Profile
LPM Leuprolide - Drug Profile
PRX-111 - Drug Profile
Fertility Hormone - Drug Profile
Drugs For Prostate Cancer & Endometriosis - Drug Profile
JR-041 - Drug Profile
JR-041 - Drug Profile
PGL1001 - Drug Profile
PGL2001 - Drug Profile
PGL3001 - Drug Profile
ESN-364 - Drug Profile
OCP - Drug Profile
Elonva - Drug Profile
DA-3803 - Drug Profile
Metformin - Drug Profile
Raloxifene - Drug Profile
Letrozole - Drug Profile
Human Chorionic Gonadotropin - Drug Profile
Clomiphene Citrate - Drug Profile
Human Chorionic Gonadotropin + Clomiphene Citrate - Drug Profile
Leuprolide Acetate - Drug Profile
Microdose GnRh Agonist - Drug Profile
Metformin - Drug Profile
Metformin - Drug Profile
MPI-676 - Drug Profile
Metformin - Drug Profile
Aldactone - Drug Profile
Progesterone - Drug Profile
Synthetic Gonadotropin Releasing Hormone - Drug Profile
XM17 - Drug Profile
D-chiro-inositol - Drug Profile
Simvastatin - Drug Profile
Dexamethasone + Recombinant hCG - Drug Profile
GnRH agonist - Drug Profile
KLH-2109 - Drug Profile
Femara - Drug Profile
Neupogen - Drug Profile
Recombinant Follicle Stimulating Hormone - Drug Profile
Metformin + Clomiphene - Drug Profile
Tamoxifen + Clomiphene - Drug Profile
Prod 5 - Drug Profile
Flutamide + Metformin - Drug Profile
Heparin - Drug Profile
Clomiphene Citrate + Dexamethasone - Drug Profile
Medroxyprogesterone - Drug Profile
Metformin - Drug Profile
Aspirin - Drug Profile
Oral Infertility Drugs - Drug Profile
DR-2011 - Drug Profile
Afolia - Drug Profile
ASP1707 - Drug Profile
Neupogen - Drug Profile
Isifera - Drug Profile
Endole - Drug Profile
FSH-GEX - Drug Profile
AKP-501 - Drug Profile
IVF001 - Drug Profile
IVF002 - Drug Profile
Prod 6 - Drug Profile
Female Infertility Therapeutics – Drug Profile Updates
Female Infertility Therapeutics – Discontinued Products
Female Infertility Therapeutics - Dormant Products
Female Infertility – Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Female Infertility, H1 2012
Products under Development for Female Infertility – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Development by Companies, H1 2012 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012 (Contd..1)
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Abbott Laboratories, H1 2012
Vyteris, Inc., H1 2012
Watson Pharmaceuticals, Inc., H1 2012
Merck & Co., Inc., H1 2012
Euroscreen S.A., H1 2012
Takeda Pharmaceutical Company Limited, H1 2012
ASKA Pharmaceutical Co., Ltd, H1 2012
Astellas Pharma Inc., H1 2012
Dong-A Pharmaceutical Co., Ltd., H1 2012
Kissei Pharmaceutical Co., Ltd., H1 2012
Teva Pharmaceutical Industries Limited, H1 2012
Zydus Cadila Healthcare Limited, H1 2012
Pantec Biosolutions AG, H1 2012
Merck KGaA, H1 2012
Access Pharmaceuticals, Inc., H1 2012
Addex Pharmaceuticals, H1 2012
AEterna Zentaris Inc., H1 2012
Soligenix, Inc., H1 2012
Repros Therapeutics Inc., H1 2012
Protalix BioTherapeutics, Inc., H1 2012
Glycotope GmbH, H1 2012
Peptron, Inc., H1 2012
Meditrina Pharmaceuticals, Inc., H1 2012
PregLem SA, H1 2012
Ferring Pharmaceuticals, Inc., H1 2012
Isifer AB, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Female Infertility Therapeutics – Drug Profile Updates
Female Infertility Therapeutics – Discontinued Products
Female Infertility Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Female Infertility, H1 2012
Products under Development for Female Infertility – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Discovery and Pre-Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos